<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 55-year-old Korean woman was initially diagnosed with <z:hpo ids='HP_0004820'>acute myelomonocytic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>After induction chemotherapy was performed using <z:chebi fb="0" ids="28680">cytarabine</z:chebi>, <z:chebi fb="0" ids="42068">idarubicin</z:chebi>, and G-CSF, complete remission (CR) was subsequently achieved following reinduction chemotherapy using the same chemotherapeutic agents </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty-six months after the initial CR, an increase in immature cells (up to 12.0%) was observed in the patient's bone marrow </plain></SENT>
<SENT sid="3" pm="."><plain>Because chromosome analysis revealed a karyotype of 46,XX,del(7)(q22) in <z:hpo ids='HP_0000001'>all</z:hpo> of the analyzed cells, the patient was diagnosed with therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>Although the patient subsequently received chemotherapy and G-CSF for <z:hpo ids='HP_0001875'>neutropenia</z:hpo>, t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> rapidly progressed after 3 months to therapy-related <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>Although very rare, de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> can progress to a <z:e sem="disease" ids="C0280745" disease_type="Neoplastic Process" abbrv="">secondary MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with del(7q) after chemotherapy with <z:chebi fb="0" ids="28680">cytarabine</z:chebi>, <z:chebi fb="0" ids="42068">idarubicin</z:chebi>, and G-CSF </plain></SENT>
<SENT sid="6" pm="."><plain>Further investigation into the role of genes located in 7q22 may provide more information about the mechanisms of <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
</text></document>